Clinico-pathological Profile of Lung Cancer at AIIMS: A Changing Paradigm in India

被引:57
作者
Malik, Prabhat Singh [1 ]
Sharma, Mehar Chand [2 ]
Mohanti, Bidhu Kalyan [3 ]
Shukla, N. K. [4 ]
Deo, S. V. S. [4 ]
Mohan, Anant [5 ]
Kumar, Guresh [6 ]
Raina, Vinod [1 ]
机构
[1] All India Inst Med Sci, Dept Med Oncol, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
[2] All India Inst Med Sci, Dept Pathol, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
[3] All India Inst Med Sci, Dept Radiat Oncol, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
[4] All India Inst Med Sci, Dept Surg Oncol, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
[5] All India Inst Med Sci, Dept Pulm Med, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
[6] All India Inst Med Sci, Dept Biostat, Dr BRA Inst Rotary Canc Hosp, New Delhi, India
关键词
Lung cancer; clinicopathological profile; pathology review; NSCLC; survival; India; UNITED-STATES; EPIDEMIOLOGY; SURVIVAL; DETERMINANTS; SURVEILLANCE; HISTOLOGY; PATTERNS; TOBACCO; CARE;
D O I
10.7314/APJCP.2013.14.1.489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lung cancer is one of the commonest and most lethal cancers throughout the world. The epidemiological and pathological profile varies among different ethnicities and geographical regions. At present adenocarcinoma is the commonest histological subtype of non-small cell lung cancer (NSCLC) in most of the Western and Asian countries. However, in India squamous cell carcinoma has been reported as the commonest histological type in most of the series. The aim of the study was to analyze the current clinico-pathological profile and survival of lung cancer at our centre. Materials and Methods: We analyzed 434 pathologically confirmed lung cancer cases registered at our centre over a period of three years. They were evaluated for their clinical and pathological profiles, treatment received and outcome. The available histology slides were reviewed by an independent reviewer. Results: Median age was 55 years with a male: female ratio of 4.6:1. Some 68% of patients were smokers. There were 85.3% NSCLC and 14.7% SCLC cases. Among NSCLCs, adenocarcinoma was the commonest histological subtype after the pathology review. Among NSCLC, 56.8% cases were of stage IV while among SCLC 71.8% cases had extensive stage disease. Some 29% of patients did not receive any anticancer treatment. The median overall and progression free survivals of the patients who received treatment were 12.8 and 7.8 months for NSCLC and 9.1 and 6.8 months for SCLC. Conclusions: This analysis suggests that adenocarcinoma may now be the commonest histological subtype also in India, provided a careful pathological review is done. Most of the patients present at advanced stage and outcome remains poor.
引用
收藏
页码:489 / 494
页数:6
相关论文
共 35 条
[1]   SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626
[2]   DETERMINANTS OF IMPROVED OUTCOME IN SMALL-CELL LUNG-CANCER - AN ANALYSIS OF THE 2,580-PATIENT SOUTHWEST ONCOLOGY GROUP DATA-BASE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1563-1574
[3]  
[Anonymous], REV MAL RESP
[4]  
Behera D, 2004, INDIAN J CHEST DIS, P269
[5]   4-year mortality in patients with non-small-cell lung cancer: Development and validation of a prognostic index [J].
Blanchon, Francois ;
Grivaux, Michel ;
Asselain, Bernard ;
Lebas, Francois-Xavier ;
Orlando, Jean-Pierre ;
Piquet, Jacques ;
Zureik, Mahmoud .
LANCET ONCOLOGY, 2006, 7 (10) :829-836
[6]  
Cetin Karynsa, 2011, Clin Epidemiol, V3, P139, DOI 10.2147/CLEP.S17191
[7]   What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements [J].
Cooper, Wendy A. ;
O'Toole, Sandra ;
Boyer, Michael ;
Horvath, Lisa ;
Mahar, Annabelle .
PATHOLOGY, 2011, 43 (02) :103-115
[8]   Factors Associated With Decisions to Undergo Surgery Among Patients With Newly Diagnosed Early-Stage Lung Cancer [J].
Cykert, Samuel ;
Dilworth-Anderson, Peggye ;
Monroe, Michael H. ;
Walker, Paul ;
McGuire, Franklin R. ;
Corbie-Smith, Giselle ;
Edwards, Lloyd J. ;
Bunton, Audrina Jones .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (23) :2368-2376
[9]   The role of radiotherapy in cancer treatment - Estimating optimal utilization from a review of evidence-based clinical guidelines [J].
Delaney, G ;
Jacob, S ;
Featherstone, C ;
Barton, M .
CANCER, 2005, 104 (06) :1129-1137
[10]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247